文献速递免疫规划传染病防控与疫情报告

VP1 G-H环高变表位对猪口蹄疫病毒保护性免疫的贡献

The VP1 G-H loop hypervariable epitope contributes to protective immunity against Foot and Mouth Disease Virus in swine.
PubMed 文献 · Vaccine · 2019-05-10

研究用PRRS病毒异源表位替换口蹄疫病毒VP1 G-H环高变表位,构建改良腺病毒载体疫苗(Ad5-FMDxeno),并比较其与原始Ad5-FMD及PBS在猪中的免疫原性和攻毒保护效果。结果显示原始疫苗可保护猪免受病变、发热和病毒血症,而替换表位后中和抗体下降、出现临床 signs 和病毒血症,提示该高变表位对Ad5载体口蹄疫疫苗的保护性免疫不可或缺。

要点

  • VP1 G-H环高变表位替换后中和抗体下降,免疫反应转向非中和表位
  • 原始Ad5-FMD疫苗保护猪免受病变、发热和病毒血症
  • 替换表位疫苗仅部分降低病毒血症和临床表现,不能完全保护

核心结论

  • VP1 G-H环高变表位对Ad5载体口蹄疫疫苗在猪中诱导的保护性免疫有贡献,不能被异源表位替换而不损失免疫原性。

研究设计与样本

  • 研究为动物实验:猪分别接种Ad5-FMD、改良Ad5-FMDxeno或PBS,接种后21天用O1 Manisa株口蹄疫病毒皮内攻毒。

主要发现

  • Ad5-FMDxeno组血清总抗体滴度显著高于Ad5-FMD组,但攻毒前中和抗体滴度低于Ad5-FMD组。
  • Ad5-FMD组猪未出现病变、发热和病毒血症;Ad5-FMDxeno组出现临床 signs 和病毒血症,但程度低于PBS对照组。
  • 两个Ad5-FMD疫苗接种组间鼻腔排毒无显著差异。

临床怎么用

  • 提示口蹄疫腺病毒载体疫苗设计应保留VP1 G-H环高变表位以维持中和抗体和保护效果。
  • 替换高变表位可能导致免疫转向非中和表位,减弱攻毒保护。

局限性

  • 原文摘要未报告样本量、具体抗体数值、P值及统计学细节。
  • 研究仅涉及O1 Manisa株攻毒和特定腺病毒载体平台,外推需谨慎。
  • 摘要未说明长期免疫持久性和田间适用性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Foot and Mouth Disease is a highly contagious and economically important disease of livestock. While vaccination is often effective at controlling viral spread, failures can occur due to strain mismatch or viral mutation. Foot and Mouth Disease Virus (FMDV) possesses a hypervariable region within the G-H Loop of VP1, a capsid protein commonly associated with virus neutralization. Here, we investigate the effect of replacement of the G-H loop hypervariable epitope with a xenoepitope from PRRS virus on the immunogenicity and efficacy of an adenovirus vectored FMDV vaccine (Ad5-FMD). Pigs were vaccinated with Ad5-FMD, the modified Ad5-FMDxeno, or PBS, followed by intradermal challenge with FDMV strain O1 Manisa at 21 days post-vaccination. While overall serum antibody titers were significantly higher in Ad5-FMDxeno vaccinated animals, neutralizing antibody titers were decreased in pigs that received Ad5-FMDxeno, when compared to those vaccinated with Ad5-FMD, prior to viral challenge, indicative of immune redirection away from VP1 towards non-neutralizing epitopes. As expected, animals vaccinated with unmodified Ad5-FMD were protected from lesions, fever, and viremia. In contrast, animals vaccinated with Ad5-FMDxeno developed clinical signs and viremia, but at lower levels than that observed in PBS-treated controls. No significant difference was found in nasal shedding of virions between the two Ad5-FMD vaccinated groups. This data suggests that the hypervariable epitope of the VP1 G-H loop contributes to protective immunity conferred by Ad5 vector-delivered FMD vaccines in swine, and cannot be substituted without a loss of immunogenicity.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Fernandez-Sainz I, Gavitt TD, Koster M, et al. The VP1 G-H loop hypervariable epitope contributes to protective immunity against Foot and Mouth Disease Virus in swine. Vaccine. 2019. PMID: 31085001. doi:10.1016/j.vaccine.2019.05.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。